Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$17,500.00
Technological Comparison of Short-Read and Long-Read Next-Generation Sequencing (NGS) Platforms for the Surveillance of the Gut Microbiome in Pediatric Inflammatory Bowel Disease (IBD)
EF 2021-22
Résumé
The
human gut microbiome represents the trillions of microbes and the
environment within the gut. Recent research suggests that the gut
microbiome is intimately linked with human health, and a dysregulated
microbiome is associated with the development of chronic illnesses like
inflammatory bowel disease (IBD). Thus, accurately assessing changes to
the microbiome composition is paramount for understanding such diseases.
To survey bacterial populations, which constitute an essential part of the
gut microbiome, a fast and economical method called 16S rRNA (16S)
sequencing is often used. Using DNA reading machines (sequencers), fingerprint DNA
sequences present in all bacteria are analyzed. This fingerprint DNA
is called the 16S
gene and
can be used to distinguish between different bacteria. However, standard
DNA sequencers can only read sections of DNA long enough to span parts of
the 16S gene (short-read), allowing distinction of most but
not all bacteria.
More sophisticated approaches to read all DNA in samples, that provide
much more information, can be prohibitively expensive and not feasible for
large sample sizes. Recently developed sequencers can read the entire 16S
gene (long-read) at similar costs to short-read sequencers. My project
will compare different short- and long-read sequencing technologies using
pediatric IBD patient samples. Long-read 16S
sequencing could potentially detect related but distinct bacteria that
could not be detected using short-read technologies.
This will enable more in-depth microbiome analysis without breaking the
bank, leading to better understanding of the links between the gut
microbiome and diseases like IBD. Ultimately, this brings us a step closer
to improved therapeutics and outcomes for IBD patients.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
475260
Name
Shin Kenny K
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Technological Comparison of Short-Read and Long-Read Next-Generation Sequencing (NGS) Platforms for the Surveillance of the Gut Microbiome in Pediatric Inflammatory Bowel Disease (IBD)
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Shotgun Metagenomic Sequencing; 16s Rrna Sequencing; Bioinformatics; Gut Microbiome; Inflammatory Bowel Disease (Ibd); Long-Read Sequencing; Nanopore Sequencing; Personalized Medicine; Synthetic Long-Read (Slr)
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Shin, Kenny K
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~
Abstract
<html>
<head>
</head>
<body>
<span align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none"><font color="rgb(0, 0, 0)" face="Verdana, Arial, Helvetica, sans-serif" size="12.8px">The
human gut microbiome represents the trillions of microbes and the
environment within the gut. Recent research suggests that the gut
microbiome is intimately linked with human health, and a dysregulated
microbiome is associated with the development of chronic illnesses like
inflammatory bowel disease (IBD). Thus, accurately assessing changes to
the microbiome composition is paramount for understanding such diseases.
To survey bacterial populations, which constitute an essential part of the
gut microbiome, a fast and economical method called 16S rRNA (16S)
sequencing is often used. Using DNA reading machines (sequencers),</font></span><font color="rgb(0, 0, 0)" face="Verdana, Arial, Helvetica, sans-serif" size="12.8px"><span> </span><em align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)">fingerprint</em><span> </span><span align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none">DNA
sequences present in all bacteria are analyzed. This</span><span> </span><em align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)">fingerprint</em><span> </span><span align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none">DNA
is called the</span><span> </span><em align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)">16S
gene</em><span> </span><span align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none">and
can be used to distinguish between different bacteria. However, standard
DNA sequencers can only read sections of DNA long enough to span parts of
the 16S gene (short-read), allowing distinction of</span><span> </span><em align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)">most<span> </span></em><span align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none">but
not</span><span> </span><em align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)">all</em><span> </span><span align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none">bacteria.
More sophisticated approaches to read all DNA in samples, that provide
much more information, can be prohibitively expensive and not feasible for
large sample sizes. Recently developed sequencers can read the entire 16S
gene (long-read) at similar costs to short-read sequencers. My project
will compare different short- and long-read sequencing technologies using
pediatric IBD patient samples.</span><span> </span><em align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)">Long-read</em><span> </span><span align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none">16S
sequencing could potentially detect related but distinct bacteria that
could not be detected using</span><span> </span><em align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)">short-read</em><span> </span><span align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none">technologies.
This will enable more in-depth microbiome analysis without breaking the
bank, leading to better understanding of the links between the gut
microbiome and diseases like IBD. Ultimately, this brings us a step closer
to improved therapeutics and outcomes for IBD patients.</span></font>
</body>
</html>